- call +1-201-465-4211
- email sales@mrinsights.biz
Female infertility refers to infertility in female humans.
Scope of the Report:
The major factors that are augmenting the growth of the female infertility market are changing life style and increasing IVF market. Furthermore, rising trend of surrogacy, growing infertility rate among female, new technologies to avoid multiple embryo implants are the also estimated to be the major factors that are contributing significantly towards the growth of the market.
The global Female Infertility Diagnosis and Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Female Infertility Diagnosis and Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Female Infertility Diagnosis and Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Female Infertility Diagnosis and Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Bayer
Bristol-Myers Squibb
Church & Dwight
Cook Medical
CooperSurgical
Eli Lilly
EMD Serono
Endo
Ferring Pharmaceuticals
Genea
GSK
Halotech DNA
Irvine Scientific
Janssen
Merck
Novartis
Origio
Pfizer
OvaScience
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Drugs and medicine
Surgical
Intrauterine insemination (IUI)
Assisted reproductive technology (ART)
Market Segment by Applications, can be divided into
Hospitals and Clinics
Diagnostic Centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Female Infertility Diagnosis and Treatment Market Overview
1.1 Product Overview and Scope of Female Infertility Diagnosis and Treatment
1.2 Classification of Female Infertility Diagnosis and Treatment by Types
1.2.1 Global Female Infertility Diagnosis and Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Female Infertility Diagnosis and Treatment Revenue Market Share by Types in 2017
1.2.3 Drugs and medicine
1.2.4 Surgical
1.2.5 Intrauterine insemination (IUI)
1.2.6 Assisted reproductive technology (ART)
1.3 Global Female Infertility Diagnosis and Treatment Market by Application
1.3.1 Global Female Infertility Diagnosis and Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.4 Global Female Infertility Diagnosis and Treatment Market by Regions
1.4.1 Global Female Infertility Diagnosis and Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Female Infertility Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Female Infertility Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Female Infertility Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Female Infertility Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Female Infertility Diagnosis and Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Female Infertility Diagnosis and Treatment (2013-2023)
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Female Infertility Diagnosis and Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Female Infertility Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bristol-Myers Squibb
2.2.1 Business Overview
2.2.2 Female Infertility Diagnosis and Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bristol-Myers Squibb Female Infertility Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Church & Dwight
2.3.1 Business Overview
2.3.2 Female Infertility Diagnosis and Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Church & Dwight Female Infertility Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Cook Medical
2.4.1 Business Overview
2.4.2 Female Infertility Diagnosis and Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Cook Medical Female Infertility Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 CooperSurgical
2.5.1 Business Overview
2.5.2 Female Infertility Diagnosis and Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 CooperSurgical Female Infertility Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Eli Lilly
2.6.1 Business Overview
2.6.2 Female Infertility Diagnosis and Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eli Lilly Female Infertility Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 EMD Serono
2.7.1 Business Overview
2.7.2 Female Infertility Diagnosis and Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 EMD Serono Female Infertility Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Endo
2.8.1 Business Overview
2.8.2 Female Infertility Diagnosis and Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Endo Female Infertility Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Ferring Pharmaceuticals
2.9.1 Business Overview
2.9.2 Female Infertility Diagnosis and Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Ferring Pharmaceuticals Female Infertility Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.10 Genea
2.10.1 Business Overview
2.10.2 Female Infertility Diagnosis and Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Genea Female Infertility Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.11 GSK
2.11.1 Business Overview
2.11.2 Female Infertility Diagnosis and Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 GSK Female Infertility Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.12 Halotech DNA
2.12.1 Business Overview
2.12.2 Female Infertility Diagnosis and Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Halotech DNA Female Infertility Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.13 Irvine Scientific
2.13.1 Business Overview
2.13.2 Female Infertility Diagnosis and Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Irvine Scientific Female Infertility Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.14 Janssen
2.14.1 Business Overview
2.14.2 Female Infertility Diagnosis and Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Janssen Female Infertility Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.15 Merck
2.15.1 Business Overview
2.15.2 Female Infertility Diagnosis and Treatment Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Merck Female Infertility Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.16 Novartis
2.16.1 Business Overview
2.16.2 Female Infertility Diagnosis and Treatment Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Novartis Female Infertility Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.17 Origio
2.17.1 Business Overview
2.17.2 Female Infertility Diagnosis and Treatment Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Origio Female Infertility Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.18 Pfizer
2.18.1 Business Overview
2.18.2 Female Infertility Diagnosis and Treatment Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Pfizer Female Infertility Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.19 OvaScience
2.19.1 Business Overview
2.19.2 Female Infertility Diagnosis and Treatment Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 OvaScience Female Infertility Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Female Infertility Diagnosis and Treatment Market Competition, by Players
3.1 Global Female Infertility Diagnosis and Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Female Infertility Diagnosis and Treatment Players Market Share
3.2.2 Top 10 Female Infertility Diagnosis and Treatment Players Market Share
3.3 Market Competition Trend
4 Global Female Infertility Diagnosis and Treatment Market Size by Regions
4.1 Global Female Infertility Diagnosis and Treatment Revenue and Market Share by Regions
4.2 North America Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
5 North America Female Infertility Diagnosis and Treatment Revenue by Countries
5.1 North America Female Infertility Diagnosis and Treatment Revenue by Countries (2013-2018)
5.2 USA Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6 Europe Female Infertility Diagnosis and Treatment Revenue by Countries
6.1 Europe Female Infertility Diagnosis and Treatment Revenue by Countries (2013-2018)
6.2 Germany Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.4 France Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Female Infertility Diagnosis and Treatment Revenue by Countries
7.1 Asia-Pacific Female Infertility Diagnosis and Treatment Revenue by Countries (2013-2018)
7.2 China Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.5 India Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
8 South America Female Infertility Diagnosis and Treatment Revenue by Countries
8.1 South America Female Infertility Diagnosis and Treatment Revenue by Countries (2013-2018)
8.2 Brazil Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Female Infertility Diagnosis and Treatment by Countries
9.1 Middle East and Africa Female Infertility Diagnosis and Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Female Infertility Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
10 Global Female Infertility Diagnosis and Treatment Market Segment by Type
10.1 Global Female Infertility Diagnosis and Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Female Infertility Diagnosis and Treatment Market Forecast by Type (2018-2023)
10.3 Drugs and medicine Revenue Growth Rate (2013-2023)
10.4 Surgical Revenue Growth Rate (2013-2023)
10.5 Intrauterine insemination (IUI) Revenue Growth Rate (2013-2023)
10.6 Assisted reproductive technology (ART) Revenue Growth Rate (2013-2023)
11 Global Female Infertility Diagnosis and Treatment Market Segment by Application
11.1 Global Female Infertility Diagnosis and Treatment Revenue Market Share by Application (2013-2018)
11.2 Female Infertility Diagnosis and Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals and Clinics Revenue Growth (2013-2018)
11.4 Diagnostic Centers Revenue Growth (2013-2018)
12 Global Female Infertility Diagnosis and Treatment Market Size Forecast (2018-2023)
12.1 Global Female Infertility Diagnosis and Treatment Market Size Forecast (2018-2023)
12.2 Global Female Infertility Diagnosis and Treatment Market Forecast by Regions (2018-2023)
12.3 North America Female Infertility Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Female Infertility Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Female Infertility Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.6 South America Female Infertility Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Female Infertility Diagnosis and Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Female Infertility Diagnosis and Treatment Picture
Table Product Specifications of Female Infertility Diagnosis and Treatment
Table Global Female Infertility Diagnos
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
